SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-143826
Filing Date
2022-05-06
Accepted
2022-05-06 17:23:53
Documents
5
Period of Report
2022-05-06

Document Format Files

Seq Description Document Type Size
1 6-K d308730d6k.htm 6-K 11532
2 EX-99.1 d308730dex991.htm EX-99.1 18759
3 EX-99.2 d308730dex992.htm EX-99.2 44421
4 GRAPHIC g308730g0505011055745.jpg GRAPHIC 4996
5 GRAPHIC g308730g0505011055988.jpg GRAPHIC 964
  Complete submission text file 0001193125-22-143826.txt   84427
Mailing Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435
Business Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435 32 10 394 100
Celyad Oncology SA (Filer) CIK: 0001637890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37452 | Film No.: 22902464
SIC: 2834 Pharmaceutical Preparations